These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 17964031)

  • 41. Primary central nervous system lymphoma: a review.
    McAllister LD
    Curr Neurol Neurosci Rep; 2002 May; 2(3):210-5. PubMed ID: 11936999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic implication of p27 expression in primary central nervous system lymphoma.
    Kunishio K; Nagao S
    Brain Tumor Pathol; 2006 Oct; 23(2):77-81. PubMed ID: 18095123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of primary central nervous system lymphoma.
    Ekenel M; DeAngelis LM
    Curr Neurol Neurosci Rep; 2007 May; 7(3):191-9. PubMed ID: 17488584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.
    Chanswangphuwana C; Rojnuckarin P; Cherdchoo N; Raiyawa T; Uaprasert N
    Hematology; 2018 Aug; 23(7):385-390. PubMed ID: 29256330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-grade central nervous system lymphoma: clarity through a hazy lens.
    Hauser SL
    Ann Neurol; 2006 May; 59(5):9A-10A. PubMed ID: 16634011
    [No Abstract]   [Full Text] [Related]  

  • 46. Update on the management of primary CNS lymphoma.
    Nasir S; DeAngelis LM
    Oncology (Williston Park); 2000 Feb; 14(2):228-34; discussion 237-42, 244. PubMed ID: 10736810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary CNS lymphoma: 5-year survival in relation to dosage of methotrexate and radiation.
    Meyer MA
    Ann Hematol; 2004 Aug; 83(8):549. PubMed ID: 15052370
    [No Abstract]   [Full Text] [Related]  

  • 48. Therapeutic management of primary CNS lymphoma in immunocompetent patients.
    Reni M; Ferreri AJ
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):382-94. PubMed ID: 12113105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary central nervous system lymphoma: a study of clinicopathological features and trend in western India.
    Pasricha S; Gupta A; Gawande J; Trivedi P; Patel D
    Indian J Cancer; 2011; 48(2):199-203. PubMed ID: 21768666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary central nervous system lymphoma in the elderly: the Cleveland clinic experience.
    Xie H; Dahiya S; Murphy ES; Chao ST; Suh JH; Stevens GH; Peereboom DM; Ahluwalia MS
    Anticancer Res; 2013 Aug; 33(8):3251-8. PubMed ID: 23898087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary central nervous system lymphoma: overview of current treatment strategies.
    Brastianos PK; Batchelor TT
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):897-916. PubMed ID: 22794289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mobilization of hemopoietic stem cells with high-dose methotrexate plus granulocyte-colony-stimulating factor in patients with primary central nervous system lymphoma.
    Kiefer T; Krüger WH; Montemurro M; Schüler F; Hirt C; Pasold R; Niederwieser D; Schwenke M; Dölken G
    Transfusion; 2008 Dec; 48(12):2624-8. PubMed ID: 18801020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Results of treatment of 112 cases of primary CNS lymphoma.
    Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
    Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Primary central nervous lymphoma: what is the role for radiotherapy?].
    Bellefqih S; Mezouri I; Khalil J; Bazine A; Diakité A; El Kacimi H; Kebdani T; Benjaafar N
    Cancer Radiother; 2014 Nov; 18(7):685-92. PubMed ID: 25451676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary CNS lymphoma.
    Maher EA; Fine HA
    Semin Oncol; 1999 Jun; 26(3):346-56. PubMed ID: 10375091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved survival with combined chemo-radiotherapy in primary central nervous system lymphoma.
    Abdelsalam M; El-Husseiny G; Akhtar S; Khafaga Y; Al-Shabana M; AlHusaini H; El Weshi A; Rahal M; Maghfoor I
    Hematol Oncol Stem Cell Ther; 2010; 3(3):128-34. PubMed ID: 20890070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgery for primary central nervous system lymphoma: is it time for reevaluation?
    Bierman PJ
    Oncology (Williston Park); 2014 Jul; 28(7):632-7. PubMed ID: 25144286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Late relapse in primary central nervous system lymphoma: clonal persistence.
    Nayak L; Hedvat C; Rosenblum MK; Abrey LE; DeAngelis LM
    Neuro Oncol; 2011 May; 13(5):525-9. PubMed ID: 21372070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An update on therapy of primary central nervous system lymphoma.
    Deangelis LM; Iwamoto FM
    Hematology Am Soc Hematol Educ Program; 2006; ():311-6. PubMed ID: 17124077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan.
    Makino K; Nakamura H; Kino T; Takeshima H; Kuratsu J
    Surg Neurol; 2006 Nov; 66(5):503-6. PubMed ID: 17084198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.